American Society of Hematology

Access Programs for Imatinib


Updated on: February 17, 2016

Drug Company Assistance

  The Novartis Patient Assistance Foundation (PAF) can help patients acquire high cost drugs either for free or at reduced process. For help acquiring imatinib, visit the online enrollment page, select imatinib, and fill in the required information.  To receive free medication, patients must be US residents, meet income criteria, and not have private or public prescription coverage.  Please note that there are exceptions for patients that cannot afford Medicare Part D or B cost sharing.

PAF enrollment is quick, and Novartis recommends that either the patient or provider call 1-888-903-7277 to complete the screening process.  Applications can be obtained online, filled out, and faxed to 1-855-817-2711.  To apply online, please visit the patient portal and register as a new user.

For patients not meeting the PAF enrollment criteria, the Patient Assistance NOW Oncology (PANO) program may be able to provide information about other funding sources or assisting with denials and appeals.  Providers should fill out the PANO form and fax it to 1-888-891-4924.

 Foundation Assistance

  Diplomat Financial Assistance offers co-pay assistance for imatinib.  Please fill out the online form to determine eligibility.

  The Health Well Foundation provides grants for patients with insurance who still have trouble affording imatinib.  Patients or providers can apply online or call 1-800-675-8416 to speak with a representative.

  The Patient Advocate Foundation offers financial support for insured patients who cannot afford their medications.  You can view the eligibility requirements for their co-pay relief program and apply online.  For further assistance, please call 1-866-512-3861, option 1 to speak with a representative.

  The Patient Access Network Foundation also offers co-pay assistance for patients needing imatinib.  Please read the application instructions  , and then follow the prompts on the online application  .

back to top